Arcturus Therapeutics Holdings, Inc. (ARCT)
6.71
-0.32
(-4.55%)
USD |
NASDAQ |
May 19, 15:44
Arcturus Therapeutics Holdings Research and Development Expense (Quarterly) : 20.92M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Twist Bioscience Corp. | 19.70M |
| Denali Therapeutics, Inc. | 103.85M |
| Agenus, Inc. | 11.82M |
| Curis, Inc. | 6.449M |
| LadRx Corp. | 0.0288M |